US Stock MarketDetailed Quotes

BNTX BioNTech

Watchlist
  • 119.870
  • +1.330+1.12%
Trading Nov 27 09:55 ET
28.74BMarket Cap-58904P/E (TTM)

BioNTech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioNTech Q3 2024 Earnings Date

Currency：EURNov 4, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
516.02M
1.24B
+728.78M
Beat Est.
-42.36%
+39.04%
+141.23%
EPS
-1.70
0.81
+2.51
Beat Est.
-354.39%
+22.73%
+147.52%
Analyst Rating
Strong Buy

Nov 27, 2024

BioNTech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
May 5, 20252025/Q1-- / 217.647M--
--2024/Q4-- / 1.119B--
Nov 4, 20242024/Q31.245B / 516.021M--
Aug 5, 20242024/Q2128.700M / 135.687M--
May 6, 20242024/Q1187.600M / 372.284M--
DatePeriodRevenue/EstimateEarnings Call
May 5, 20252025/Q1-- / 217.647M--
--2024/Q4-- / 1.119B--
Nov 4, 20242024/Q31.245B / 516.021M--
Aug 5, 20242024/Q2128.700M / 135.687M--
May 6, 20242024/Q1187.600M / 372.284M--

Unlock Free Earnings Estimates

BioNTech Earnings Reports

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 4 06:59 ET

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 4 06:59 ET

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 5 06:37 ET

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 5 06:37 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 27, 2024

    Strong Buy

    • Buy

      76.47%

    • Hold

      23.53%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Investment Theme Infectious Disease
    Infectious Disease
    Intraday+0.77%